Markets › India › NSE › ERIS

Eris Lifesciences Ltd

NSE:ERISHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹1,120.40−2.10%At closeAt close · Mon 19 Oct · ≈ AED 43.29 · Market cap $1.67B · Next earnings Wed 11 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	79.7%	80.3%	78.5%	80.5%	74.6%	47.9%	—	—
Operating margin	32.6%	32.1%	25.4%	24.9%	24.4%	26.9%	26.9%	+0.0 pts
Net margin	29.8%	30.6%	23.0%	19.7%	12.2%	19.8%	20.4%	+0.6 pts
EBITDA margin	36.8%	38.5%	33.0%	35.1%	36.0%	35.5%	—	—
Return on equity	22.5%	21.3%	17.4%	15.2%	12.3%	15.9%	16.4%	+0.5 pts
Return on assets	19.4%	17.9%	10.4%	5.6%	5.0%	8.4%	8.7%	+0.3 pts
Return on capital employed	23.3%	20.5%	13.1%	11.0%	12.4%	15.9%	—	—
Debt / equity	0.0×	0.0×	0.4×	1.1×	0.9×	0.6×	0.6×	+0.2%
Debt / assets	0.4%	3.7%	23.9%	39.5%	35.2%	32.0%	—	—
Interest coverage	196.8×	100.7×	16.1×	5.8×	3.0×	4.4×	—	—
Current ratio	2.8×	3.1×	1.7×	0.9×	0.9×	0.7×	0.7×	+0.0%
Quick ratio	2.2×	2.6×	1.4×	0.8×	0.6×	0.5×	—	—
Cash ratio	0.2×	0.3×	0.1×	0.0×	0.2×	0.0×	0.0×	+0.0%
Asset turnover	0.7×	0.6×	0.5×	0.3×	0.4×	0.4×	—	—
Inventory turnover	2.6×	2.2×	2.7×	2.1×	2.2×	3.7×	—	—
Receivables turnover	8.1×	6.3×	5.7×	4.7×	6.3×	4.3×	—	—
Dividend payout	21.0%	20.1%	26.1%	0.0%	28.4%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.